Death of Patient Halts Clinical Trial That Involved California Stem Cell Agency
A clinical trial based on a $4 million award from the California stem cell agency has been suspended after one of the patients died.
The phase one safety trial was being conducted by Poseida Therapuetics, Inc., of San Diego. In 2018, Poseida received $4 million for the proposed therapy from the California Institute for Regenerative Medicine (CIRM), as t…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.